New research: Lenvatinib vs sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a phase 3 trial

Linda Howard General news

Our CEO, Stacie Hudgens, is co-author of a manuscript published by The Lancet on June 1: Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial Hepatocellular carcinoma is the third-leading cause of cancer-related death worldwide. Preservation of health-related quality of life (HRQOL) during treatment is an important therapeutic goal. …

Validant acquires Clinical Outcomes Solutions, a global leader in clinical outcomes assessment research services

Linda Howard General news

Adds complementary services in high growth sub-segment of HEOR Expands geographic presence with offices across the US and UK Validant, a leading global quality, compliance and regulatory consulting group, has acquired Clinical Outcomes Solutions (“COS”), a global leader in clinical outcomes assessments (COA). COS was founded in 2013 and has developed a leadership position in COA through its patient-centered approach …

Men’s Health Week 14 – 21 June

Linda Howard General news

June 14-20 is Men’s Health Week, and we are proud to be recognising the huge contributions our global team makes to the field of men’s health research. Our colleagues work tirelessly to further research, listening to the voices of those patients living with health issues that affect men disproportionately and ultimately allowing care pathways and treatments to be personalised, responsive, and …

June 6 is global National Cancer Survivors Day

Linda Howard General news

It is a sad fact that cancer has – and likely will – touch all of our lives in some way. June 6 is global National Cancer Survivors Day. Our colleagues work tirelessly to further #oncology research, listening to the voices of those patients living with #cancer and ultimately allowing care pathways and treatments to be personalised, responsive, and effective. …

Fibromyalgia awareness day

Linda Howard General news

12 May is Fibromyalgia awareness day, and we are proud to be recognising the huge contributions our global team makes to the field of patient research. Our colleagues recognise the need to further research, listen to the voices of those living with fibromyalgia and ultimately share knowledge on treatments. View relevant publications here: Li, Y., Morris, S., Cole, J., Dube, S., …

May is Skin Cancer Awareness Month

Linda Howard General news

May is Skin Cancer Awareness Month, and we are proud to be recognising the huge contributions our global team makes to the field of oncology research. Our colleagues work tirelessly to further research, listening to the voices of those patients living with skin cancer and ultimately allowing care pathways and treatments to be personalised, responsive, and effective. View relevant publications here: Wali, …

World Asthma Day 2021

Linda Howard General news

4 May is World Asthma Day, and we are proud to be recognising the huge contributions our global team makes to the field of asthma or chronic obstructive pulmonary disease (COPD) research. Our colleagues further research by listening to the voices of patients living with respiratory issues and ultimately allowing patients affected by respiratory conditions to feel that their condition is …

Clinical Outcomes Solutions and Carevive Systems Partner to Improve the Patient Experience in Cancer Care

Linda Howard General news

We are delighted to announce that Carevive has joined the Oncology Outcomes initiative to provide life science companies with analysis of cancer patient experience data for personalised drug development and improved patient care.  As a global leader in the collection, analysis and reporting of patient-centred outcomes data, we are delighted to announce a collaborative partnership with Carevive Systems, the leading …

April is Bowel Cancer Awareness Month

Linda Howard General news

April is Bowel Cancer Awareness Month, and we are proud to be recognising the huge contributions our global team makes to the field of oncology research. Our colleagues work tirelessly to further research, listening to the voices of those patients living with bowel cancer and ultimately allowing care pathways and treatments to be personalised, responsive, and effective. View relevant publications here: Cella, …